PRPO Precipio Inc

P/E --
Forward P/E 15.43
Price/Sales 1.245
Beta 1.302
Div Yield --
Market Cap --

Company Analysis

Latest News

πŸ”΄ Precipio is trading 7% down; reason remains unclear

Precipio is trading 7% down at $18.07 on October 30, 2026; the reason for the decline remains unclear. - No clear company-specific announcement or reliable...

🟒 Precipio is trading 6% up with no clear company-specific catalyst

Precipio is trading at $19.77, up 5.84%, with no clear company-specific catalyst reported for the October 29 move. - Healthcare strength may be supportive:...

πŸ”΄ Precipio is trading 5% down today with no clear company-specific catalyst

Precipio is trading at $21.38, down 5.17%, with no clear company-specific catalyst identified for its October 16 decline. - Search results showed no...

πŸ”΄ Precipio is trading 10.18% down today as higher yields revive rate concerns

Precipio is trading 10.18% lower at $23.59 amid broad risk-off selling following higher Treasury yields and renewed inflation and interest-rate concerns. - On...

πŸ”΄ Precipio is trading 5.46% down today as yields and oil revive inflation concerns

Precipio is trading 5.46% lower at $24.83, with the move appearing primarily linked to broader risk-off sentiment. - The decline extends from the September 22...

🟒 Precipio is trading 8% up in pre-market

Precipio is trading 7.98% up at $28.36 in pre-market; no clear company-specific catalyst was identified for September 23, 2026. - September 18 results showed...

πŸ”΄ Precipio is trading 5.2% down today

Precipio is trading 5.19% down now at $25.75, with no clear company-specific catalyst identified for September 16, 2026. - The company’s official...

🟒 Precipio is trading 5.7% up today with no clear catalyst identified

Precipio is trading 5.7% up at $27.06, with no new company-specific announcement identified for September 10, 2026. - The latest listed press release was its...

πŸ”΄ Precipio is trading 5.6% down today as healthcare falls 2.19%

Precipio is trading 5.6% down at $25.73, primarily amid a healthcare-sector decline. - The stock fell from the September 8 close of $27.25; healthcare is down...

🟒 Precipio is trading 5.28% up today β€” No clear catalyst identified

Precipio is trading 5.28% up now at $27.50, with no clear company-specific catalyst identified. - No company-specific announcement dated September 2–4, 2026...

πŸ”΄ Precipio is trading 6.2% down today β€” no company-specific announcement identified

Precipio is trading 6.2% down at $24.50 after no company-specific announcement was identified for September 4, 2026. - Its investor-relations page lists...

πŸ”΄ Precipio is trading 5.1% down today with no clear company-specific catalyst identified

Precipio is trading 5.1% down now at $28.86, with no clear company-specific announcement or reliable news catalyst identified for August 27, 2026. - Its...

πŸ”΄ Precipio is trading 5.7% down today without a new company-specific catalyst

Precipio is trading 5.7% down at $27.75 after no new company-specific catalyst was identified for the August 21, 2026 decline. - The stock follows two strong...

πŸ”΄ Precipio is trading 8.26% down in pre-market; no company-specific catalyst identified

Precipio is trading 8.26% down in pre-market at $27.00 after no new company-specific explanation for the August 21 decline was identified; profit-taking or...

Precipio Hits Record Revenue and Turns Cash-Flow Positive β€” But Can a $50 Million Company Outrun Its Going-Concern Shadow?

Precipio Hits Record Revenue and Turns Cash-Flow Positive β€” But Can a $50 Million Company Outrun Its Going-Concern Shadow?

Shares surged as Precipio Diagnostics, a tiny cancer-testing firm, posted the strongest quarter in its history β€” forcing investors to weigh accelerating growth...

🟒 Precipio is trading 11.56% up today after record Q2 revenue and positive adjusted EBITDA

Precipio is trading 11.56% up at $27.55 after investors continued reacting to its August 17, 2026, second-quarter results. - Revenue reached record $7.0...